Overview
LMRI market data
Price History
LMRI price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.49 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.01 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.45 – $19.45 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1K · P/B 2.83 · P/S 0.80.
Company news
8-K filing — Lumexa Imaging Holdings, Inc. (LMRI)SEC EDGAR · Jun 30, 2026, 9:08 PM
Lumexa Imaging Forms Strategic JV With Hospital For Special Surgery To Expand Access To Advanced Outpatient Imaging Services Across New York City Metro AreaBenzinga · Jun 2, 2026, 11:14 AM
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9Benzinga · May 20, 2026, 2:00 PM
Lumexa Imaging shares are trading lower after the company narrowed its FY2026 sales guidance below estimates.Benzinga · May 13, 2026, 3:36 PM
Lumexa Imaging Holdings Q1 2026 Earnings Call TranscriptBenzinga · May 12, 2026, 10:07 PM
Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M EstimateBenzinga · May 12, 2026, 8:10 PM